Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors
Tze‐Fan Chao(National Yang Ming Chiao Tung University), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Jo‐Nan Liao(L-3 Communications (United States)), Ta‐Chuan Tuan(National Yang Ming Chiao Tung University), Fa‐Po Chung(L-3 Communications (United States)), Yu‐Feng Hu(China Agricultural University), Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Tzeng‐Ji Chen(Taipei Veterans General Hospital), Li‐Wei Lo(National Yang Ming Chiao Tung University), Gregory Y.H. Lip(University of Liverpool), Shih‐Lin Chang(National Yang Ming Chiao Tung University)
Cited by 165
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k